{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:05Z","timestamp":1761513545805},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2014,11]]},"abstract":"<jats:p>Epilepsy is very prevalent among elderly inpatients and treatment is far from ideal.  Objective To analyze prescribing patterns of antiepileptic drugs (AEDs) for hospitalized elderly with epilepsy, their relations with comorbidities and comedications.   Method We assessed prescription regimen of elderly patients that were under AED use for treatment of epileptic seizures, during hospitalization. One hundred and nine patients were enrolled. AED regimen was categorized into two groups: Group 1 defined as appropriate (carbamazepine, oxcarbazepine, valproic acid, gabapentin, clobazan and lamotrigine) and Group 2 as inappropriate (phenytoin and phenobarbital).   Results We found 73.4% of patients used inappropriate AEDs (p&lt;0.001). Monotherapy was prescribed for 71.6% of patients. The most common comorbidity was hypertension. Potentially proconvulsant drugs as comedications were used for nearly half of patients.   Conclusion Inappropriate AED therapy was commonly prescribed regimen for elderly inpatients. Some recommendations are discussed for a better care of elderly inpatients with epilepsy.<\/jats:p>","DOI":"10.1590\/0004-282x20140151","type":"journal-article","created":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T18:07:15Z","timestamp":1416074835000},"page":"874-880","source":"Crossref","is-referenced-by-count":7,"title":["Antiepileptic drugs patterns in elderly inpatients in a Brazilian tertiary center, Salvador, Brazil"],"prefix":"10.1590","volume":"72","author":[{"given":"Telma Rocha de","family":"Assis","sequence":"first","affiliation":[{"name":"Hospital S\u00e3o Rafael,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvaldo J. M.","family":"Nascimento","sequence":"additional","affiliation":[{"name":"Universidade Federal Fluminense,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gersonita","family":"Costa","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Rafael,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aroldo","family":"Bacellar","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Rafael,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","article-title":"The descriptive epidemiology of epilepsy-a review","volume":"85","author":"Banerjee PN","year":"2009","journal-title":"Epilepsy Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1586\/ern.10.170","article-title":"Epilepsy in the elderly","volume":"10","author":"Johnston A","year":"2010","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","DOI":"10.4081\/ni.2012.e17","article-title":"Status epilepticus in the elderly: epidemiology, clinical aspects and treatment","volume":"4","author":"Assis TM","year":"2012","journal-title":"Neurol Int"},{"issue":"9213","key":"ref4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0140-6736(00)02149-8","article-title":"Epilepsy in elderly people","volume":"355","author":"Stephen LJ","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/epi.12014","article-title":"Cause-specific mortality among patients with epilepsy: results from a 30-year cohort study","volume":"54","author":"Trinka E","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1749-6632.2009.05113.x","article-title":"Epilepsy in the elderly","volume":"1184","author":"Leppik IE","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.3949\/ccjm.72.Suppl_3.S26","article-title":"Seizures in the elderly: nuances in presentation and treatment","volume":"72","author":"Waterhouse E","year":"2005","journal-title":"Clev Clin J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/01.wnl.0000302370.01359.8f","article-title":"Monotherapy in adults and elderly persons","volume":"69","author":"Faught E","year":"2007","journal-title":"Neurology"},{"issue":"22 Pt 2","key":"ref9","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1212\/01.wnl.0000313157.15089.e6","article-title":"Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004","volume":"70","author":"Pugh MJ","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1532-5415.2004.52115.x","article-title":"Potentially inappropriate antiepileptic drugs for elderly patients with epilepsy","volume":"52","author":"Pugh MJ","year":"2004","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.seizure.2012.04.014","article-title":"Trends in antiepileptic drug utilisation in UK primary care 1993-2008: cohort study using the General Practice Research Database","volume":"21","author":"Nicholas JM","year":"2012","journal-title":"Seizure"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.seizure.2012.09.012","article-title":"Antiepileptic drug use in Austrian nursing home residents","volume":"22","author":"Huber DP","year":"2013","journal-title":"Seizure: J Brit Epilep Assoc"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.mcna.2006.06.002","article-title":"Elders with epilepsy","volume":"90","author":"Collins NS","year":"2006","journal-title":"Med Clin North Am"},{"issue":"3","key":"ref14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/2013.jamaneurol.337","article-title":"Hospital-onset seizures: an inpatient study","volume":"70","author":"Fields MC","year":"2013","journal-title":"JAMA Neurol"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.seizure.2006.02.002","article-title":"Antiepileptic drug use in nursing home residents: a cross-sectional, regional study","volume":"15","author":"Huying F","year":"2006","journal-title":"Seizure"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie MJ","year":"2013","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7742(06)81015-9","article-title":"Risk and predictability of drug interactions in the elderly","volume":"81","author":"Levy RH","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0074-7742(06)81011-1","article-title":"Age-related changes in pharmacokinetics: predictability and assessment methods","volume":"81","author":"Perucca E","year":"2007","journal-title":"Int Rev Neurol"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures","volume":"313","author":"Mattson RH","year":"1985","journal-title":"New Engl J Med"},{"issue":"9566","key":"ref20","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson AG","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"ref21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1212\/01.wnl.0000345667.45642.61","article-title":"Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy","volume":"72","author":"Perucca P","year":"2009","journal-title":"Neurology"},{"issue":"3 Epilepsy","key":"ref22","first-page":"136","article-title":"Antiepileptic drugs: adverse effects and drug interactions","volume":"16","author":"Tatum WO","year":"2010","journal-title":"Continuum (Minneap Minn)"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","article-title":"New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine","volume":"64","author":"Rowan AJ","year":"2005","journal-title":"Neurology"},{"issue":"9566","key":"ref24","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson AG","year":"2007","journal-title":"Lancet"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2007.01128.x","article-title":"An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly","volume":"48","author":"Saetre E","year":"2007","journal-title":"Epilepsia"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser T","year":"2013","journal-title":"Epilepsia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.WNL.0000123695.22623.32","article-title":"Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"62(8)","author":"French JA","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14737175.6.4.575","article-title":"Epileptogenic drugs: a systematic review","volume":"6","author":"Ruffmann C","year":"2006","journal-title":"Exp Rev Neurother"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.yebeh.2012.10.009","article-title":"Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?","volume":"26","author":"Hamid H","year":"2013","journal-title":"epilepsy Behav"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper K","year":"2007","journal-title":"Biol Psychiatry"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v72n11\/0004-282X-anp-72-11-874.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T22:47:05Z","timestamp":1495925225000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2014001100874&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0004-282X2014001100874"],"URL":"https:\/\/doi.org\/10.1590\/0004-282x20140151","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}